Fig. 2.
Fig. 2. FLT3 mutations (ITDs) in elderly AML patients. / (A) PCR products of the FLT3 gene after electrophoresis through a 2% agarose gel. The PCR products from a normal bone marrow (NL, left lane) and elderly AML samples 10 to 14 are demonstrated. High-molecular-weight bands in samples 11, 12, and 14 (arrows) were confirmed to have mutations by direct nucleotide sequencing. (B) SSCP analysis of PCR product from a normal bone marrow (NL, left lane) followed by elderly AML samples 45, 46, 69, 74, 85, 109, and 112. The 7 elderly AML samples had normal-appearing bands with agarose electrophoresis. Arrows point to shifted bands in patient samples 74, 109, and 112. Direct nucleotide sequencing confirmed ITDs in samples 74, 109, and 112.

FLT3 mutations (ITDs) in elderly AML patients.

(A) PCR products of the FLT3 gene after electrophoresis through a 2% agarose gel. The PCR products from a normal bone marrow (NL, left lane) and elderly AML samples 10 to 14 are demonstrated. High-molecular-weight bands in samples 11, 12, and 14 (arrows) were confirmed to have mutations by direct nucleotide sequencing. (B) SSCP analysis of PCR product from a normal bone marrow (NL, left lane) followed by elderly AML samples 45, 46, 69, 74, 85, 109, and 112. The 7 elderly AML samples had normal-appearing bands with agarose electrophoresis. Arrows point to shifted bands in patient samples 74, 109, and 112. Direct nucleotide sequencing confirmed ITDs in samples 74, 109, and 112.

Close Modal

or Create an Account

Close Modal
Close Modal